
Glenn Chertow
Nephrology · Stanford Health Care
Credentials: · · ·
History
- 1993–1995
- 1985–1989
Research
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
New England Journal of Medicine · 2004 · 9,374 citations
Dapagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine · 2020 · 4,258 citations
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
Journal of the American Society of Nephrology · 2005 · First of 5 authors · Corresponding · 2,551 citations
- GB
69 papers

66 papers

54 papers
- GK
50 papers

41 papers · 8 as a fellow

39 papers

34 papers

33 papers
Grants
- 2023–2028
Learners to LeAders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
Project lead · $1.2M · University of California, San Francisco
- 2019–2025
Stanford TRANSFORM I2T Program
National Institute of Allergy and Infectious Diseases · R25
PI · $1.8M · Stanford University
- 1980–2025
Adult and Pediatric Nephrology and Urology Research Training Program
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $4M · Stanford University
- 2023–2025
National Institute on Minority Health and Health Disparities · R21
PI · $424.6K · Stanford University
Clinical trials
- 2023
- 2021–2024
Principal investigator · Terminated · Phase 3
AstraZeneca
- 2016–2019
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
Principal investigator · Completed · Phase 4
Christopher Granger, MD
- 2006–2010
Frequent Hemodialysis Network: Daily Trial
Principal investigator · Completed · Phase 2, Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


